Wockhardt Limited, a active public limited company, was established on 08 July 1999 in Aurangabad, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: L24230MH1999PLC120720. Registered under ROC Roc Mumbai. it is listed on BSE: 532300 and NSE: WOCKPHARMA. It has an authorized capital of ₹1,125.00 Cr and a paid-up capital of ₹81.25 Cr.
Formerly known as Wockhardt Pharmaceuticals Limited. It upholds a compliant status. In 2024, it reported revenue of ₹1,195.00 Cr and a net worth of ₹1,796.00 Cr. Employing 2,065 professional, Its leadership includes Habil Fakhruddin Khorakiwala (Whole-Time Director), Javed Ahmad (Director), Amelia Fernandes (Director). Past directors included Sanjaya Baru, Gajanand Sahu, Shekhar Datta. It holds ₹1,214.65 Cr open charges and ₹10,105.27 Cr settled loans. Its latest AGM occurred on 08 August 2025, with the balance sheet filed on 31 March 2025. It is based at Wockhardt Research Centre, D-4, M.I.D.C. Chikalthana, Aurangabad, Maharashtra, 431006.
L24230MH1999PLC120720
120720
08 July 1999
₹1,125.00 Cr
₹81.25 Cr
Roc Mumbai
Listed (BSE: 532300, NSE: WOCKPHARMA)
Active
Explore comprehensive insights into Wockhardt Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Habil Fakhruddin Khorakiwala | Whole-Time Director | 08 Jul 1999 | Current |
| Javed Ahmad | Director | 28 May 2024 | Current |
| Amelia Fernandes | Director | 18 Jul 2023 | Current |
| Murtaza Habil Khorakiwala | Managing Director | 29 Jun 2009 | Current |
| Vinesh Kumar Jairath | Director | 10 Nov 2016 | Current |
| Zahabiya Habil Khorakiwala | Director | 30 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 13 Sep 2012 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 31 Mar 2019 | Past |
| Pramod Abcsdd | Managing Director | 31 Mar 2009 | Past |
| Pramod Abcsdd | Company Secretary | 09 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 27 Jun 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wockhardt Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.92% increase. The company also saw a slight improvement in profitability, with a 9.44% increase in profit. The company's net worth moved up by a moderate rise of 2.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Wockhardt had a promoter holding of 59.31% and a public holding of 40.69%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,146,500,000.00
₹101,052,667,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2025 | Others | ₹200.00 Cr | Open |
| 29 Dec 2023 | Others | ₹50.00 Cr | Open |
| 29 Jul 2021 | Others | ₹13.00 Cr | Open |
| 27 Jan 2016 | Sbicap Trustee Company Limited | ₹951.65 Cr | Open |
| 07 Dec 2023 | Others | ₹100.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Wockhardt has a workforce of 2065 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Wockhardt, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 200.00 Cr registered on 28 Jun 2025 with Charge ID 101116191 was modified on 02 Dec 2025. was completed.
Om Prakash Bhatt was appointed as a Additional Director was appointed as a Additional Director on 03 Nov 2025 & has been associated with this company since 1 month 14 days . was recorded as a recent event.
Progress on A charge with Others of Rs. 50.00 Cr registered on 29 Dec 2023 with Charge ID 100841754 was modified on 21 Aug 2025. was documented.
The activity Wockhardt Limited last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records. was completed.
The activity A charge with Sbicap Trustee Company Limited of Rs. 951.65 Cr registered on 27 Jan 2016 with Charge ID 10619036 was modified on 23 Jul 2025. was completed.
A charge with Others amounted to Rs. 200.00 Cr with Charge ID 101116191 was registered on 28 Jun 2025. was recorded as a recent event.
The company had posted a net loss of Rs 89.18 crore in the same period a year ago. .
"I believe that the development work on these drugs today will shape the global war on Antimicrobial Resistance (AMR) tomorrow," he added..
The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore..
Wockhardt's bioequivalence centre in Aurangabad, Maharashtra received zero observations from the USFDA after an inspection. This means they followed all the rules and will likely get approvals for their new drugs. #Winning #USFDA #ZeroObservations #Bioequivalence #Wockhardt.
The CIN of Wockhardt Limited is L24230MH1999PLC120720.
Wockhardt Limited is headquartered at Wockhardt Research Centre, D-4, M.I.D.C. Chikalthana, Aurangabad, Maharashtra, 431006.
Wockhardt Limited was incorporated on 08 July 1999.
The current directors of Wockhardt Limited are
The primary industry of Wockhardt Limited is Manufacturing.
Wockhardt Limited is listed. It is listed on BSE: 532300 and NSE: WOCKPHARMA.
The authorized capital of Wockhardt Limited is ₹1,125.00 Cr, and the paid-up capital is ₹81.25 Cr.
The compliance status of Wockhardt Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX